- Brazil's Temer to leave hospital, return to Brasilia
- Poland gives government key election role, opposition sounds alarm
- Prince Harry and Meghan Markle to wed on May 19, 2018
- Britain's Prince Harry and Meghan Markle to marry on May 19
- Finland lets stores sell stronger drinks, health chiefs complain
- Multi-summit Macron burns energy in hunt for results
- Erdogan says Turkey seeking to annul Trump decision on Jerusalem at U.
- Russian ex-minister Ulyukayev jailed for eight years over $2 million b
- Mexico's Senate passes divisive security law, paving way for final app
- U.S. says concerned about Myanmar's silence over where Reuters journal
- 'Congratulations': EU launches next phase of Brexit
- Novo Nordisk wins EU panel's backing for key diabetes drug
- Pakistani top court rejects bid to bar opposition leader Imran Khan
- Aclaris's drug to treat common skin growth gets FDA nod
- Catalan election to return hung parliament: poll
- Aclaris's drug to treat common growth on skin gets FDA nod
- FDA allows Alnylam to restart hemophilia treatment trials
- U.N. appalled at Iraq's latest mass hanging: spokeswoman
- Why Jerusalem's holy sites are so significant - CNN Video
- Friday protests over Trump's Jerusalem decision
Sanofi says no reported deaths in Philippines related to dengue vaccine
MANILA (Reuters) - There have been no reported deaths in the Philippines related to a suspended dengue vaccine made by Sanofi, an official from the pharmaceutical company said on Monday.
“As far as we know, as far as we are made aware, there are no reported deaths that are related to dengue vaccination,” Ruby Dizon, medical director at Sanofi Pasteur, told reporters.
“Of course, rest assured, monitoring is continuing, we are working with the Department of Health (DOH), in collaboration, to make sure this is maintained.”
Last year, more than 730,000 children in the Philippines aged 9 and above received one dose of the vaccine, Dengvaxia.
The office of the Philippine president on Sunday vowed to hold accountable those responsible for a suspended dengue immunization program that it said put thousands of lives at risk.
Reporting by Manolo Serapio Jr. and Neil Jerome Morales
Our Standards:The Thomson Reuters Trust Principles.